Skip to content

Blog
Deutsch
- Englisch
- Französisch

Was kommt als nächstes
Unsere Dienstleistungen
Unsere Expertise
Über Nexelis
Neuigkeiten und Veranstaltungen
- Nachrichten
- Veranstaltungen
Speisekarte

Back to the library

Cartilage Diseases and Arthritis

C2C (Collagend Type II Cleavage), Serum CTX-II (Carboxy-Terminal Telepeptides of Type II Collagen), Urine YKL-40

About Nexelis, a Q² Solutions Company

With unrivaled expertise in immunology, 4 operating sites in North America and Europe, and a translational offer of services covering the needs of the pharmaceutical industry from the lead selection to the late clinical stage, Nexelis, a Q² Solutions Company, is a leading provider of assay development and advanced laboratory testing services in the infectious, metabolic and oncologic fields. Our versatile team of scientists, working with state of the art technology platforms, were instrumental in the development, qualification, validation, and large-scale sample testing of assays that supported the FDA filing of almost 350 new molecular entities, including blockbuster vaccines and biologics, anti-viral drugs, immunotherapy, gene and cell therapy products.

A Q² Solutions Company

Contact Us

Q² Solutions, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions. Learn more at www.q2labsolutions.com.

Careers
Quality Assurance
Information Technology

Follow Us LinkedIn Twitter YouTube

© 2024 Nexelis, a Q² Solutions Company. All Rights Reserved.

Was kommt als nächstes
Unsere Dienstleistungen
Unsere Expertise
Über Nexelis
Neuigkeiten und Veranstaltungen
- Nachrichten
- Veranstaltungen
Speisekarte

Blog
Deutsch
- Englisch
- Französisch